GlassScriptPhysician profile
Jeremiah Ross
NPI 1669068581
$537.07
in general payments reported to CMS, 2019-2025
13 companies · $24.39 in 2025
The $24.39 reported for 2025 was less than what a typical Acute Care (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
See the full distribution for Acute Care (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $110 · 2022: $247 · 2023: $138 · 2024: $17.95 · 2025: $24.39.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $180.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $180.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shionogi INC | $137.76 | 2022-2023 | Fetroja |
| Access Pro Medical, LLC | $81.36 | 2022 | |
| Csl Behring | $48.66 | 2023 | Kcentra |
| Pfizer INC. | $46.88 | 2021-2022 | |
| Aroa Biosurgery Incorporated | $46.07 | 2023 | |
| Nestle Healthcare Nutrition INC. | $45.97 | 2021 | |
| Haemonetics Corporation | $24.39 | 2025 | Teg6s Hemostasis System |
| Alcresta Therapeutics, INC. | $23.16 | 2022 | |
| Alexion Pharmaceuticals, INC. | $19.74 | 2021 | |
| Merck Sharp & Dohme LLC | $19.08 | 2022 | |
| Melinta Therapeutics, LLC | $17.95 | 2024 | Rezzayo |
| Teleflex LLC | $13.38 | 2021 | |
| Chiesi USA, INC. | $12.67 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeremiah Ross listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.